A analysis crew of the division of biotechnology and microbiology at Kannur University, comprising Prof. A. Sabu, M. Haridas, and Prasanth Shankar, has been awarded a US patent for the invention of ‘Phormidin’ an inhibitor of the enzyme Fatty Acid Synthase (FAS).
This is the primary worldwide patent earned by the college. The award gives the promise of growing a brand new drug for most cancers remedy.
The patent comes as a end result of virtually 10 years of analysis that started in 2010 with assist from the Ministry of Earth Sciences.
According to Prof. Sabu, FAS inhibitors are anticipated to be future medicine in most cancers remedy. FAS is crucial for fats metabolism, and its inhibition results in the dying of the cell.
Phormidin has nice potential within the remedy of weight problems, diabetes, and tuberculosis. The new hope for most cancers remedy is that the medicine developed based mostly on FAS inhibitor could have higher properties with few negative effects, Prof. Sabu identified.